GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Price-to-Funds-From-Operations

Cassava Sciences (MEX:SAVA) Price-to-Funds-From-Operations : (As of Jun. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Cassava Sciences (MEX:SAVA) Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.